Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Tournayre, Sarah
7  Ergebnisse:
Personensuche X
?
1

Semaglutide as a potential treatment for obesity in Smith-K..:

Bonnet, Jean-baptiste ; Durieux, Axelle Trupheme ; Tournayre, Sarah...
Obesity Research & Clinical Practice.  18 (2024)  2 - p. 159-162 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Factors associated with meropenem pharmacokinetic/pharmacod..:

Tournayre, Sarah ; Mathieu, Olivier ; Villiet, Maxime...
International Journal of Antimicrobial Agents.  62 (2023)  2 - p. 106868 , 2023
Link: https://doi.org/10.1016/..
 
?
3

Semaglutide 2.4 mg/wk for weight loss in patients with seve..:

Bonnet, Jean‐Baptiste ; Tournayre, Sarah ; Anitcheou, Jean...
Obesity.  32 (2023)  1 - p. 50-58 , 2023
Link: https://doi.org/10.1002/..
 
?
4

Semaglutide 2.4 mg/wk for weight loss in patients with seve..:

Bonnet, Jean‐baptiste ; Tournayre, Sarah ; Anitcheou, Jean...
info:eu-repo/semantics/altIdentifier/doi/10.1002/oby.23922.  , 2024
Link: https://hal.science/hal-..
 
?
5

Semaglutide 2.4 mg/wk for weight loss in patients with seve..:

Bonnet, Jean‐baptiste ; Tournayre, Sarah ; Anitcheou, Jean...
info:eu-repo/semantics/altIdentifier/doi/10.1002/oby.23922.  , 2024
Link: https://hal.science/hal-..
 
?
6

Factors associated with meropenem pharmacokinetic/pharmacod..:

Tournayre, Sarah ; Mathieu, Olivier ; Villiet, Maxime...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.ijantimicag.2023.106868.  , 2023
Link: https://hal.science/hal-..
 
?
7

Factors associated with meropenem pharmacokinetic/pharmacod..:

Tournayre, Sarah ; Mathieu, Olivier ; Villiet, Maxime...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.ijantimicag.2023.106868.  , 2023
Link: https://hal.science/hal-..
 
1-7